Genetically engineered models relevant to neurodegenerative disorders: Their value for understanding disease mechanisms and designing/testing experimental therapeutics

P. C. Wong, H. Cai, D. R. Borchelt, D. L. Price

    Research output: Contribution to journalArticle

    Abstract

    Significant progress in the identification of disease-specific genes for a variety of neurodegenerative diseases have provided opportunities to understand molecular mechanisms and to test experimental therapeutic for these disorders. Recent works on clarifying the selective vulnerability of neurons and pathogenic mechanisms using genetically engineered mouse models of familial forms of Alzheimer's disease and motor neuron disease will be reviewed.

    Original languageEnglish (US)
    Pages (from-to)233-257
    Number of pages25
    JournalJournal of Molecular Neuroscience
    Volume17
    Issue number2
    DOIs
    StatePublished - 2001

    Fingerprint

    Motor Neuron Disease
    Neurodegenerative Diseases
    Alzheimer Disease
    Neurons
    Testing
    Neurodegenerative diseases
    Genes
    Therapeutics

    Keywords

    • Disease mechanisms
    • Experimental therapeutics
    • Neurodegenerative diseases
    • Selective vulnerability
    • Transgenic models

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Biochemistry
    • Genetics

    Cite this

    Genetically engineered models relevant to neurodegenerative disorders : Their value for understanding disease mechanisms and designing/testing experimental therapeutics. / Wong, P. C.; Cai, H.; Borchelt, D. R.; Price, D. L.

    In: Journal of Molecular Neuroscience, Vol. 17, No. 2, 2001, p. 233-257.

    Research output: Contribution to journalArticle

    @article{52544c7562e441e6b17b80d57332b374,
    title = "Genetically engineered models relevant to neurodegenerative disorders: Their value for understanding disease mechanisms and designing/testing experimental therapeutics",
    abstract = "Significant progress in the identification of disease-specific genes for a variety of neurodegenerative diseases have provided opportunities to understand molecular mechanisms and to test experimental therapeutic for these disorders. Recent works on clarifying the selective vulnerability of neurons and pathogenic mechanisms using genetically engineered mouse models of familial forms of Alzheimer's disease and motor neuron disease will be reviewed.",
    keywords = "Disease mechanisms, Experimental therapeutics, Neurodegenerative diseases, Selective vulnerability, Transgenic models",
    author = "Wong, {P. C.} and H. Cai and Borchelt, {D. R.} and Price, {D. L.}",
    year = "2001",
    doi = "10.1385/JMN:17:2:233",
    language = "English (US)",
    volume = "17",
    pages = "233--257",
    journal = "Journal of Molecular Neuroscience",
    issn = "0895-8696",
    publisher = "Humana Press",
    number = "2",

    }

    TY - JOUR

    T1 - Genetically engineered models relevant to neurodegenerative disorders

    T2 - Their value for understanding disease mechanisms and designing/testing experimental therapeutics

    AU - Wong, P. C.

    AU - Cai, H.

    AU - Borchelt, D. R.

    AU - Price, D. L.

    PY - 2001

    Y1 - 2001

    N2 - Significant progress in the identification of disease-specific genes for a variety of neurodegenerative diseases have provided opportunities to understand molecular mechanisms and to test experimental therapeutic for these disorders. Recent works on clarifying the selective vulnerability of neurons and pathogenic mechanisms using genetically engineered mouse models of familial forms of Alzheimer's disease and motor neuron disease will be reviewed.

    AB - Significant progress in the identification of disease-specific genes for a variety of neurodegenerative diseases have provided opportunities to understand molecular mechanisms and to test experimental therapeutic for these disorders. Recent works on clarifying the selective vulnerability of neurons and pathogenic mechanisms using genetically engineered mouse models of familial forms of Alzheimer's disease and motor neuron disease will be reviewed.

    KW - Disease mechanisms

    KW - Experimental therapeutics

    KW - Neurodegenerative diseases

    KW - Selective vulnerability

    KW - Transgenic models

    UR - http://www.scopus.com/inward/record.url?scp=0035169490&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0035169490&partnerID=8YFLogxK

    U2 - 10.1385/JMN:17:2:233

    DO - 10.1385/JMN:17:2:233

    M3 - Article

    C2 - 11816796

    AN - SCOPUS:0035169490

    VL - 17

    SP - 233

    EP - 257

    JO - Journal of Molecular Neuroscience

    JF - Journal of Molecular Neuroscience

    SN - 0895-8696

    IS - 2

    ER -